Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine
The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable p...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Watson, Alan B [verfasserIn] Marley, John E [verfasserIn] Ellis, David H [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Oxford, UK: Blackwell Publishing Ltd ; 1998 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
Online-Ressource |
|---|
| Reproduktion: |
2007 ; Blackwell Publishing Journal Backfiles 1879-2005 |
|---|---|
| Übergeordnetes Werk: |
In: Australasian journal of dermatology - Oxford : Wiley-Blackwell, 1967, 39(1998), 1, Seite 0 |
| Übergeordnetes Werk: |
volume:39 ; year:1998 ; number:1 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1111/j.1440-0960.1998.tb01237.x |
|---|
| Katalog-ID: |
NLEJ242323405 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ242323405 | ||
| 003 | DE-627 | ||
| 005 | 20230505195422.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 120427s1998 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/j.1440-0960.1998.tb01237.x |2 doi | |
| 035 | |a (DE-627)NLEJ242323405 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a Watson, Alan B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine |
| 264 | 1 | |a Oxford, UK |b Blackwell Publishing Ltd |c 1998 | |
| 300 | |a Online-Ressource | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine. | ||
| 533 | |d 2007 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2007|||||||||| | ||
| 650 | 4 | |a fungal infection | |
| 700 | 1 | |a Marley, John E |e verfasserin |4 aut | |
| 700 | 1 | |a Ellis, David H |e verfasserin |4 aut | |
| 700 | 1 | |a Williams, Tony G |4 oth | |
| 773 | 0 | 8 | |i In |t Australasian journal of dermatology |d Oxford : Wiley-Blackwell, 1967 |g 39(1998), 1, Seite 0 |h Online-Ressource |w (DE-627)NLEJ243927444 |w (DE-600)2003697-8 |x 1440-0960 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:1998 |g number:1 |g pages:0 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1440-0960.1998.tb01237.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DJB | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 1998 |e 1 |h 0 | ||
| author_variant |
a b w ab abw j e m je jem d h e dh dhe |
|---|---|
| matchkey_str |
article:14400960:1998----::ogemolwpfainsihonioyhmcssfet |
| hierarchy_sort_str |
1998 |
| publishDate |
1998 |
| allfields |
10.1111/j.1440-0960.1998.tb01237.x doi (DE-627)NLEJ242323405 DE-627 ger DE-627 rakwb Watson, Alan B verfasserin aut Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine Oxford, UK Blackwell Publishing Ltd 1998 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| fungal infection Marley, John E verfasserin aut Ellis, David H verfasserin aut Williams, Tony G oth In Australasian journal of dermatology Oxford : Wiley-Blackwell, 1967 39(1998), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927444 (DE-600)2003697-8 1440-0960 nnns volume:39 year:1998 number:1 pages:0 http://dx.doi.org/10.1111/j.1440-0960.1998.tb01237.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1998 1 0 |
| spelling |
10.1111/j.1440-0960.1998.tb01237.x doi (DE-627)NLEJ242323405 DE-627 ger DE-627 rakwb Watson, Alan B verfasserin aut Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine Oxford, UK Blackwell Publishing Ltd 1998 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| fungal infection Marley, John E verfasserin aut Ellis, David H verfasserin aut Williams, Tony G oth In Australasian journal of dermatology Oxford : Wiley-Blackwell, 1967 39(1998), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927444 (DE-600)2003697-8 1440-0960 nnns volume:39 year:1998 number:1 pages:0 http://dx.doi.org/10.1111/j.1440-0960.1998.tb01237.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1998 1 0 |
| allfields_unstemmed |
10.1111/j.1440-0960.1998.tb01237.x doi (DE-627)NLEJ242323405 DE-627 ger DE-627 rakwb Watson, Alan B verfasserin aut Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine Oxford, UK Blackwell Publishing Ltd 1998 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| fungal infection Marley, John E verfasserin aut Ellis, David H verfasserin aut Williams, Tony G oth In Australasian journal of dermatology Oxford : Wiley-Blackwell, 1967 39(1998), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927444 (DE-600)2003697-8 1440-0960 nnns volume:39 year:1998 number:1 pages:0 http://dx.doi.org/10.1111/j.1440-0960.1998.tb01237.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1998 1 0 |
| allfieldsGer |
10.1111/j.1440-0960.1998.tb01237.x doi (DE-627)NLEJ242323405 DE-627 ger DE-627 rakwb Watson, Alan B verfasserin aut Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine Oxford, UK Blackwell Publishing Ltd 1998 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| fungal infection Marley, John E verfasserin aut Ellis, David H verfasserin aut Williams, Tony G oth In Australasian journal of dermatology Oxford : Wiley-Blackwell, 1967 39(1998), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927444 (DE-600)2003697-8 1440-0960 nnns volume:39 year:1998 number:1 pages:0 http://dx.doi.org/10.1111/j.1440-0960.1998.tb01237.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1998 1 0 |
| allfieldsSound |
10.1111/j.1440-0960.1998.tb01237.x doi (DE-627)NLEJ242323405 DE-627 ger DE-627 rakwb Watson, Alan B verfasserin aut Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine Oxford, UK Blackwell Publishing Ltd 1998 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| fungal infection Marley, John E verfasserin aut Ellis, David H verfasserin aut Williams, Tony G oth In Australasian journal of dermatology Oxford : Wiley-Blackwell, 1967 39(1998), 1, Seite 0 Online-Ressource (DE-627)NLEJ243927444 (DE-600)2003697-8 1440-0960 nnns volume:39 year:1998 number:1 pages:0 http://dx.doi.org/10.1111/j.1440-0960.1998.tb01237.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 39 1998 1 0 |
| source |
In Australasian journal of dermatology 39(1998), 1, Seite 0 volume:39 year:1998 number:1 pages:0 |
| sourceStr |
In Australasian journal of dermatology 39(1998), 1, Seite 0 volume:39 year:1998 number:1 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
fungal infection |
| isfreeaccess_bool |
false |
| container_title |
Australasian journal of dermatology |
| authorswithroles_txt_mv |
Watson, Alan B @@aut@@ Marley, John E @@aut@@ Ellis, David H @@aut@@ Williams, Tony G @@oth@@ |
| publishDateDaySort_date |
1998-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ243927444 |
| id |
NLEJ242323405 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242323405</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505195422.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s1998 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1440-0960.1998.tb01237.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242323405</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Watson, Alan B</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2007</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2007||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">fungal infection</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marley, John E</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ellis, David H</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williams, Tony G</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Australasian journal of dermatology</subfield><subfield code="d">Oxford : Wiley-Blackwell, 1967</subfield><subfield code="g">39(1998), 1, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243927444</subfield><subfield code="w">(DE-600)2003697-8</subfield><subfield code="x">1440-0960</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:1998</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1440-0960.1998.tb01237.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">1998</subfield><subfield code="e">1</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
| author |
Watson, Alan B |
| spellingShingle |
Watson, Alan B misc fungal infection Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine |
| authorStr |
Watson, Alan B |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243927444 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
NL |
| publishPlace |
Oxford, UK |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1440-0960 |
| topic_title |
Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine fungal infection |
| publisher |
Blackwell Publishing Ltd |
| publisherStr |
Blackwell Publishing Ltd |
| topic |
misc fungal infection |
| topic_unstemmed |
misc fungal infection |
| topic_browse |
misc fungal infection |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
t g w tg tgw |
| hierarchy_parent_title |
Australasian journal of dermatology |
| hierarchy_parent_id |
NLEJ243927444 |
| hierarchy_top_title |
Australasian journal of dermatology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ243927444 (DE-600)2003697-8 |
| title |
Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine |
| ctrlnum |
(DE-627)NLEJ242323405 |
| title_full |
Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine |
| author_sort |
Watson, Alan B |
| journal |
Australasian journal of dermatology |
| journalStr |
Australasian journal of dermatology |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1998 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Watson, Alan B Marley, John E Ellis, David H |
| container_volume |
39 |
| physical |
Online-Ressource |
| format_se |
Elektronische Aufsätze |
| author-letter |
Watson, Alan B |
| doi_str_mv |
10.1111/j.1440-0960.1998.tb01237.x |
| author2-role |
verfasserin |
| title_sort |
long-term follow up of patients with toenail onychomycosis after treatment with terbinafine |
| title_auth |
Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine |
| abstract |
The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine. |
| abstractGer |
The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine. |
| abstract_unstemmed |
The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine. |
| collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
| container_issue |
1 |
| title_short |
Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine |
| url |
http://dx.doi.org/10.1111/j.1440-0960.1998.tb01237.x |
| remote_bool |
true |
| author2 |
Marley, John E Ellis, David H Williams, Tony G |
| author2Str |
Marley, John E Ellis, David H Williams, Tony G |
| ppnlink |
NLEJ243927444 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth |
| doi_str |
10.1111/j.1440-0960.1998.tb01237.x |
| up_date |
2024-07-06T01:35:33.838Z |
| _version_ |
1803791613389963264 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242323405</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230505195422.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s1998 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1440-0960.1998.tb01237.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242323405</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Watson, Alan B</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The long-term outcome of 111 patients treated with oral terbinafine for toenail onychomycosis with a novel treatment protocol was assessed a median of 138 weeks alter entry into the trial. All but three patients had either one or two 12 week courses of terbinafine 250 mg daily. 01 the 77 evaluable patients, 72.7% were still classified as responders (i.e. negative mycological culture and at least 3 mm olnew unaffected nail growth) on reassessment. The present study shows that a favourable long-term outcome can be achieved in patients who have been treated with at least one 12 week course of terbinafine.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2007</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2007||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">fungal infection</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marley, John E</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ellis, David H</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williams, Tony G</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Australasian journal of dermatology</subfield><subfield code="d">Oxford : Wiley-Blackwell, 1967</subfield><subfield code="g">39(1998), 1, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243927444</subfield><subfield code="w">(DE-600)2003697-8</subfield><subfield code="x">1440-0960</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:1998</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1440-0960.1998.tb01237.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">1998</subfield><subfield code="e">1</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.400342 |